STORZ MODULITH LITHOTRIPTER, MODEL SLX FOR FRAGMENTATION OF URINARY AND UPPER URETERAL CALCULI (MOBILE VERSION)

FDA Premarket Approval P920051 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval of a mobile version of the modulith(r) slx lithotripter. The device, as modified, will be marketed under the trade name the storz modulith(r) slx mobile lithotripter, and is indicated for use in the noninvasive gragmentation of urinary calculi in the kidney and upper ureter.

DeviceSTORZ MODULITH LITHOTRIPTER, MODEL SLX FOR FRAGMENTATION OF URINARY AND UPPER URETERAL CALCULI (MOBILE VERSION)
Generic NameLithotriptor, Extracorporeal Shock-wave, Urological
ApplicantKARL STORZ ENDOSCOPY-AMERICA, INC.
Date Received1996-08-30
Decision Date1997-01-10
PMAP920051
SupplementS004
Product CodeLNS 
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address KARL STORZ ENDOSCOPY-AMERICA, INC. 1201 Roberts Blvd. kennesaw, GA 30144

Supplemental Filings

Supplement NumberDateSupplement Type
P920051Original Filing
S007 1997-10-02 Special (immediate Track)
S006 1997-03-26 Real-time Process
S005 1996-10-08 Normal 180 Day Track
S004 1996-08-30 Normal 180 Day Track
S003 1996-04-17 Normal 180 Day Track
S002 1995-09-18 Normal 180 Day Track
S001 1995-07-24 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.